Irvine, CA, United States of America

Guang-Wei Lu

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Twi Biotechnology, Inc., Twi Pharmaceuticals, Inc.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guang-Wei Lu. Retrieved from https://idiyas.com/inventor/guang-wei-lu-oyordsgs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Guang-Wei Lu

Introduction

Guang-Wei Lu is a notable inventor based in Irvine, CA, who has made significant contributions to the field of pharmaceuticals. He holds 2 patents that focus on topical formulations for treating autoimmune diseases. His work exemplifies the intersection of innovation and healthcare, aiming to improve patient outcomes through advanced therapeutic solutions.

Latest Patents

One of Guang-Wei Lu's latest patents involves a topical formulation comprising a therapeutically effective amount of tofacitinib. This formulation includes at least one solvent and optionally one or more other pharmaceutically acceptable excipients. The patent also outlines a method for treating and/or preventing autoimmune diseases in a subject by administering the topical formulation. This innovative approach highlights the potential of tofacitinib in addressing complex health issues.

Career Highlights

Throughout his career, Guang-Wei Lu has worked with several companies, including Twi Pharmaceuticals, Inc. and Twi Biotechnology, Inc. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical formulations and innovations.

Collaborations

Guang-Wei Lu has collaborated with notable professionals in his field, including Chih-Ming Chen and Ling-Ying Liaw. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Guang-Wei Lu's contributions to pharmaceutical innovations, particularly in the area of topical formulations for autoimmune diseases, demonstrate his commitment to improving healthcare solutions. His work continues to inspire advancements in the field and showcases the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…